Clinical Trials
11 trialsNCT00072462 2024-09-19
IBIS-II DCIS
Queen Mary University of London
Phase 3 Completed
NCT00026286 2023-06-15
Hormone Replacement Therapy for Hot Flashes and/or Vaginal Symptoms in Postmenopausal Women Receiving Tamoxifen for Breast Cancer
Eastern Cooperative Oncology Group
Phase 3 Completed
NCT00003857 2022-05-25
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Radiation Therapy Oncology Group
Phase 3 Completed
NCT02961790 2020-01-18
Oxybutynin Chloride in Managing Hot Flashes
Academic and Community Cancer Research United
Phase 3 Completed
NCT00053898 2018-09-20
Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy
NSABP Foundation Inc
Phase 3 Completed
NCT00004205 2017-12-12
BIG 1-98
ETOP IBCSG Partners Foundation
Phase 3 Completed
NCT00438659 2016-08-01
Mometasone Furoate in Preventing Radiation Dermatitis in Patients Undergoing Radiation Therapy to the Breast or Chest Wall for Invasive Breast Cancer or Ductal Carcinoma in Situ
Alliance for Clinical Trials in Oncology
Phase 3 Completed
NCT00538850 2014-03-05
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
INSYS Therapeutics Inc
Phase 3 Completed
NCT00003771 2013-09-20
Hormone Replacement Therapy and the Risk of Breast Cancer Recurrence in Women With Previous Early Stage Breast Cancer
National Cancer Institute (NCI)
Phase 3 Completed
NCT00262899 2013-01-07
Genetic Counseling or Usual Care in Helping Women With Newly Diagnosed Ductal Carcinoma In Situ or Stage I, Stage II, or Stage IIIA Breast Cancer Make Treatment Decisions
Georgetown University
Phase 3 Completed
NCT00002920 2012-10-31
S9630, Medroxyprogesterone in Treating Women With Breast Cancer
SWOG Cancer Research Network
Phase 3 Completed